时代财经AI快讯,4月30日,丸美生物(603983.SH)发布公告,2026年一季度营业收入8.81亿元,同比增长4.09%;归属于上市公司股东的净利润为1.01亿元,同比下降25.20%;基本每股收益为0.25元/股,同比下降26.47%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.